Interleukin-10 Inhibits the In vitro Proliferation of Human Activated Leukemic CD5⁺ B-Cells

References

• Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Ann. Rev. Immunol. 1993; 11: 165
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R., Haanen J., Spits H., Roncarolo M-G., te Velde A., Figdor C.G., Johnson K., Kastelein R., Yssel H., de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 1991; 174: 915
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Defrance T., Perrone C., Vezzio N., Hsu D-H., Kastelein R., Moore K.W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 1992; 89: 1890
   PubMed Web of Science ®Google Scholar
• Fluckiger A.C., Garrone P., Durand I., Galizzi J-P., Banchereau J. Interleukin 10 upregulates functional high affinity 1L-2 receptors on normal and leukemic B lymphocytes. J. Exp. Med. 1993; 178: 1473
   PubMed Web of Science ®Google Scholar
• Armitage R.J., Macduff B.M., Spriggs M.K., Fanslow W.C. Human B-cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 1993; 150: 3671
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B-cells to secrete immunoglobulin. A. J. Exp. Med. 1992; 175: 671
   PubMed Web of Science ®Google Scholar
• Briere F., Servet-Delprat C., Bridon J-M., Saint-Remy J-M., Banchereau J. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B-cells to secrete IgG1 and IgG3. J. Exp. Med. 1994; 179: 757
   PubMed Web of Science ®Google Scholar
• Arpin C., Dechanet J., van Kooten C., Merville P., Grouard G., Briere F., Banchereau J., Liu Y-J. Generation of memory B-cells and plasma cells in vitro. Science 1995; 268: 720
   PubMed Web of Science ®Google Scholar
• Levy Y., Brouet J.C. Interleukin-10 prevents spontaneous death of germinal centre B-cells by induction of the bcl-2 protein. J. Clin. Invest. 1994; 93: 424
   PubMed Web of Science ®Google Scholar
• Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C., Binet J-L., French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 1991; 78: 1901
   PubMed Web of Science ®Google Scholar
• Freedman A.S., Nadler L.M. Immunologic markers in B-cell chronic lymphocytic leukemia. Chronic lymphocytic leukemia. Scientific advances and clinical developments, B.D. Cheson. Marcel Dekkerlnc, New York 1992; 1
   Google Scholar
• Lydyard P.M., Youinou P.Y. Human CD5+ (B1) B-cells in health and disease. Fund. Clin. Immunol. 1994; 2: 9
   Web of Science ®Google Scholar
• Fluckiger A-C., Durand I., Banchereau J. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp. Med. 1994; 179: 91
   PubMed Web of Science ®Google Scholar
• Itoh K., Hirohata S. The role of IL-10 in human B-cell activation, proliferation and differentiation. J. Immunol. 1995; 154: 4341
   PubMed Web of Science ®Google Scholar
• Tangye S.G., Weston K.M., Raison R.L. Phorbol ester activates CD5+ leukemic B-cells via a T-cell independent mechanism. Immunol. Celt Biol. 1995; 73: 44
   PubMed Web of Science ®Google Scholar
• Tangye S.G., Weston K.M., Raison R.L. Cytokines and cross-linking slgM augment PMA-induced activation of human leukemic CD5+ B-cells. Immunol. Cell Biol. 1997, In press
   Web of Science ®Google Scholar
• Tangye S.G., Raison R.L. Human cytokines suppress apoptosis of leukemic CD5+ B-cells and preserve expression of Bcl-2. Immunol. Cell Biol. 1997; 75: 127
   PubMed Web of Science ®Google Scholar
• Ho A. S-Y., Moore K.W. Interleukin-10 and its receptor. Ther. Immunol. 1994; 1: 173
   PubMedGoogle Scholar
• Jurlander J., Lai C.-F., Tan J., Chou C.-C., Geisler C.H., Schriber J., Blumenson L.E., Narula S.K., Baumann H., Caligiuri M.A. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 1997; 89: 4146
   PubMed Web of Science ®Google Scholar
• Sarfati M. Interleukin-4 and the two isoforms of CD23 antigen: their possible contribution to the physiopathol-ogy of chronic lymphocytic leukemia. Nouv. Rev. Fr. Hematol. 1993; 35: 109
   PubMedGoogle Scholar
• van Kooten C., Rensink I., Aarden L., van Oers R. Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leuk. Lymphoma. 1993; 12: 27
   PubMed Web of Science ®Google Scholar
• Hoffbrand A.V., Panayiotidis P., Reittie J., Ganeshaguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin. Hematol. 1993; 30: 306
   PubMed Web of Science ®Google Scholar
• Carlsson M., Sundstrom C., Bengtsson M., Totterman T.H., Rosen A., Nilsson K. Interleukin-4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals. Eur. J. Immunol. 1989; 19: 913
   PubMed Web of Science ®Google Scholar
• van Kooten C., Rensink I., Aarden L., van Oers R. Effect of IL-4 and IL-6 on the proliferation and differentiation of B chronic lymphocytic leukemia cells. Leukemia 1993; 7: 618
   PubMed Web of Science ®Google Scholar
• Fluckiger A.C., Rossi J.F., Bussel A., Bryon P., Banchereau J., Defrance T. Responsiveness of chronic lymphocytic leukemia B-cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173
   PubMed Web of Science ®Google Scholar
• Fluckiger A-C., Briere F., Zurawski G., Bridon J-M., Banchereau J. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukemia cells. Immunology 1994; 83: 397
   PubMed Web of Science ®Google Scholar
• Dancescu M., Rubio-Trujillo M., Biron G., Bron D., Delespesse G., Sarfati M. Interleukin-4 protects chronic lymphocytic leukemia cells from death by apoptotis and upregulates bcl-2 expression. J. Exp. Med. 1992; 176: 1319
   PubMed Web of Science ®Google Scholar
• Panayiotidis P., Ganeshaguru K., Jabbar S.A.B., Hoffbrand A.V. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukemia cells in vitro. Br. J. Haem. 1993; 85: 439
   PubMed Web of Science ®Google Scholar
• Aderka D., Maor Y., Novick D., Engelmann H., Kahn Y., Levo Y., Wallach D., Revel M. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-α or -(5. Blood 1993; 81: 2076
   PubMed Web of Science ®Google Scholar
• Luo H., Rubio M., Biron G., Delespesse G., Sarfati M. Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukemia. J. Immunother. 1991; 10: 418
   PubMed Web of Science ®Google Scholar
• Burdin N., Peronne C., Banchereau J., Rousset F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 1993; 177: 295
   PubMed Web of Science ®Google Scholar
• Nilsson K. The control of growth and differentiation in chronic lymphocytic leukemia (B-CLL) cells. Chronic Lymphocytic Leukemia. Scientific Advances and Clinical Developments, B.D. Cheson. Marcel Dekker Inc., New York 1992; 33
   Google Scholar
• Tangye S.G., Raison R.L. Leukemic CD5+ B-cell apoptosis: Co-incidence of cell death and DNA fragmentation with reduced bcl-2 expression. Br. J. Haem. 1996; 92: 950
   PubMed Web of Science ®Google Scholar
• Marcelletti J.F. IL-10 inhibits lipopolysaccharideinduced murine B-cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response. J. Immunol. 1996; 157: 3323
   PubMed Web of Science ®Google Scholar
• Finke J., Ternes P., Lange W., Mertelsmann R., Dolken G. Expression of interleukin 10 in B lymphocytes of different origin. Leukemia 1993; 7: 1852
   PubMed Web of Science ®Google Scholar
• Sjoberg J., Aguilar-Santelises M., Sjogren A.M., Pisa E.K., Ljungdahl A., Bjorkholm M., Jondal M., Mellstedt H., Pisa P. Interleukin-10 mRNA expression in B-cell chronic B lymphocytic leukemia inversely correlates with progression of disease. Br. J. Haem. 1996; 92: 393
   PubMed Web of Science ®Google Scholar